Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.34
+0.09 (1.71%)
Aug 27, 2026, 1:56 PM HKT

HKG:2566 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,2631,8551,620---
Market Cap Growth
-64.71%14.54%----
Enterprise Value
7181,4191,716---
Last Close Price
5.257.486.49---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.9512.0510.98---
PS Ratio
0.841.281.11---
PB Ratio
0.651.011.00---
P/TBV Ratio
0.751.011.00---
P/FCF Ratio
-8.1219.10---
P/OCF Ratio
-6.5416.06---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.480.981.18---
EV/EBITDA Ratio
3.367.168.38---
EV/EBIT Ratio
4.109.0310.27---
EV/FCF Ratio
-6.2120.24---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.110.100.080.190.290.28
Debt / EBITDA Ratio
1.020.900.620.962.701.32
Debt / FCF Ratio
-0.791.521.46-15.02
Net Debt / Equity Ratio
-0.28-0.33-0.320.050.140.11
Net Debt / EBITDA Ratio
-2.55-3.10-2.550.241.290.50
Net Debt / FCF Ratio
--2.69-6.160.36-141.555.61
Asset Turnover
0.620.650.851.020.94-
Inventory Turnover
1.671.661.801.741.45-
Quick Ratio
3.753.973.661.881.621.34
Current Ratio
4.294.464.132.422.131.87
Return on Equity (ROE)
8.49%8.74%11.47%14.39%8.07%-
Return on Assets (ROA)
4.52%4.37%6.08%6.81%2.39%-
Return on Invested Capital (ROIC)
10.79%11.41%13.13%13.48%5.51%15.36%
Return on Capital Employed (ROCE)
8.30%7.90%9.90%14.30%5.40%16.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
12.75%8.30%9.11%---
FCF Yield
-12.31%5.24%---
Dividend Yield
1.26%0.85%0.92%---
Payout Ratio
-9.92%--20.04%-
Buyback Yield / Dilution
-7.43%-20.16%-2.11%---
Total Shareholder Return
-6.18%-19.31%-1.20%---